Hallworth G W, Westmoreland D G
Inhalation Technology Department, Glaxo Group Research Ltd, Ware, Herts, UK.
J Pharm Pharmacol. 1987 Dec;39(12):966-72. doi: 10.1111/j.2042-7158.1987.tb03142.x.
The development is described of the twin impinger, a two-stage separation device for assessing the drug delivery from metered dose inhalers and other oral inhalation delivery devices. The discharged aerosol is fractionated by firing through a simulated oropharynx and then through an impinger stage of defined aerodynamic particle size cut-off characteristics. The fine (pulmonary) fraction which penetrates is collected by a lower impinger. It is demonstrated that this device is able to assess individually the fine particle delivery of both components of two-drug aerosols. Formulations showing undue agglomeration or serious crystal growth of drug are readily detected. The twin impinger is shown to be a valuable device for routine quality assessment of aerosols during product development, stability testing and for quality assurance and comparison of commercial products.
本文描述了双撞击器的研发情况,它是一种用于评估定量吸入器和其他口服吸入给药装置药物递送情况的两级分离装置。排出的气雾剂通过模拟口咽喷射,然后通过具有特定空气动力学粒径截止特性的撞击器阶段进行分级。穿透的细颗粒(肺部)部分由下部撞击器收集。结果表明,该装置能够单独评估双药气雾剂两种成分的细颗粒递送情况。易于检测到药物出现过度团聚或严重晶体生长的制剂。双撞击器被证明是一种在产品研发、稳定性测试期间对气雾剂进行常规质量评估以及对商业产品进行质量保证和比较的有价值的装置。